Global Pharma Tek India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
- Revenue Growth 482.32%
- Profit Growth 245.40%
- Ebitda 169.06%
- Net Worth 166.60%
- Total Assets 53.10%
About Global Pharma Tek India
Global Pharma Tek India Private Limited (GPTIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 2015 (Nine years and four months 25 days old ). Its registered office is in Guntur, Andhra Pradesh, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.50 Cr.
Anupama Anumala and Narasimharao Anumala serve as directors at the Company.
Company Details
-
Location
Guntur, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74900AP2015PTC097342
-
Company No.
097342
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Sep 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Global Pharma Tek India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupama Anumala
|
Director | 14-Mar-2016 | Current |
|
Narasimharao Anumala
|
Director | 08-Jun-2019 | Current |
Financial Performance of Global Pharma Tek India.
Global Pharma Tek India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 482.32% increase. The company also saw a substantial improvement in profitability, with a 245.4% increase in profit. The company's net worth Soared by an impressive increase of 166.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Global Pharma Tek India?
Unlock access to Global Pharma Tek India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Qualigence Health India Private LimitedNarasimharao Anumala is a mutual person
-
Paramolz Private LimitedAnupama Anumala and Narasimharao Anumala are mutual person
-
Capleo Global Solutions Private Limited
Anupama Anumala and Narasimharao Anumala are mutual person
Charges (Loans)
₹25.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2023 | Axis Bank Limited | ₹2.50 Cr | Open |
How Many Employees Work at Global Pharma Tek India?
Global Pharma Tek India has a workforce of 46 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Global Pharma Tek India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Pharma Tek India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
